Brevan Howard Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,682	Closed	-$131K	–	1388
2024 Q3	$131K	Buy	+15,682	New	+$131K	﹤0.01%	998
2024 Q1	–	Sell	-10,842	Closed	-$70.4K	–	1294
2023 Q4	$70.4K	Buy	+10,842	New	+$70.4K	﹤0.01%	933